Clinical Trials Logo
  1. Home
  2. Soft Tissue Infections
  3. NCT00303589

A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Soft Tissue Infections Clinical Trial

Official title:
A Phase II Prospective, Open Label, Randomized, Active-controlled, Parallel Group, Multi-center 'Proof of Concept' Trial in Adult Patients With Complicated Skin or Skin Structure Infections Requiring Hospitalization.

Clinical Trial Summary

This 3 arm study will compare the efficacy and safety of beta-lactam with that of 'standard care' in patients with complicated skin and skin structure infections requiring hospitalization. Patients will be randomized to receive 1)beta-lactam 750mg iv q8h 2)beta-lactam 1500mg iv q8h or 3)'standard care' [PRP (nafcillin or flucloxacillin) or vancomycin, plus aztreonam or ciprofloxacin]. The anticipated time on study treatment is <3 months and the target sample size is 100-500 individuals.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00303589
Study type Interventional
Source Hoffmann-La Roche
Contact
Status Completed
Phase Phase 2
Start date December 2005
Completion date October 2007
View Details
See also
  Status Clinical Trial Phase
Completed NCT04332679 - Non-resorbable Membranes Versus Titanium Meshes and Resorbable Membranes N/A
Completed NCT00187759 - Placebo Controlled Study of Antibiotic Treatment of Soft Tissue Infection N/A
Completed NCT02097615 - Diabetic Foot Ulcer. Effectiveness of Chlorhexidine Gluconate 0.125 % Compared With Sterile Deionized Water Phase 4
Completed NCT01557426 - Soft Tissue Ultrasound of Infections Phase 1
Active, not recruiting NCT04257097 - Reinforced PTFE Meshes Versus Customized Titanium Meshes N/A
Enrolling by invitation NCT05826873 - Discharge Stewardship in Children's Hospitals N/A
Completed NCT04393909 - Improving Safety of Diagnosis and Therapy in the Inpatient Setting N/A
Active, not recruiting NCT02595047 - Autologous Prefabrication of Body Surface Tissues/ Organs(e.g. Joint) N/A
Completed NCT01790698 - Systems Medicine to Study Necrotizing Soft Tissue Infections (NSTIs).
Completed NCT00785200 - MRSA Colonization and Control in the Dallas County Jail N/A
Completed NCT00426933 - Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections Phase 2
Terminated NCT00102947 - Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections Phase 4
Completed NCT00451386 - Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036) Phase 2
Completed NCT03643952 - Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029) Phase 2
Recruiting NCT02979951 - Fosfomycin i.v. for Treatment of Severely Infected Patients
Completed NCT02600871 - Skin and Soft Tissue Infection (SSTI) Study Phase 4
Completed NCT04286334 - Three-dimensional Bone Regeneration Using Custom-made Meshes With and Without Collagen Membrane N/A
Recruiting NCT05471908 - Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial N/A
Withdrawn NCT03982030 - Dalbavancin Outpatient Pilot Phase 4
Terminated NCT00430937 - Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections Phase 3